Form 8-K - Current report:
SEC Accession No. 0001564590-20-051310
Filing Date
2020-11-05
Accepted
2020-11-05 16:11:03
Documents
14
Period of Report
2020-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20201103.htm   iXBRL 8-K 41008
2 EX-99.1 xene-ex991_6.htm EX-99.1 246879
3 GRAPHIC glkuvqeytdv0000001.jpg GRAPHIC 7563
  Complete submission text file 0001564590-20-051310.txt   445947

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA xene-20201103.xsd EX-101.SCH 5792
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20201103_lab.xml EX-101.LAB 19435
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20201103_pre.xml EX-101.PRE 11629
7 EXTRACTED XBRL INSTANCE DOCUMENT xene-8k_20201103_htm.xml XML 3536
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 201290537
SIC: 2834 Pharmaceutical Preparations